Understanding the Immune Response to Meningitis Vaccines

NCT00901940 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Meningitis
Septicemia

Interventions

BIOLOGICAL: Meningococcal (Groups A, C, Y and W-135) Conjugate
BIOLOGICAL: Meningococcal polysaccharide A, C, Y and W135 and Menveo

Sponsor

University of Oxford

Collaborators

[object Object]